Added to YB: 2017-03-21
Pitch date: 2017-03-21
GILD:US [bullish]
Gilead Sciences, Inc.
+123.82%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
Market Cap
$149.4B
Pitch Price
$53.44
Price Target
N/A
Dividend
2.62%
EV/EBITDA
11.45
P/E
18.75
EV/Sales
5.63
Sector
Biotechnology
Category
N/A
Show full summary:
Gilead Sciences, Inc. GILD:US
A summary for this pitch has not been created yet.
Read full article (0 min)